Rafferty Asset Management »

Monte Rosa Therapeutics shares owned by Rafferty Asset Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Rafferty Asset Management from 13F filings

Historical chart of Rafferty Asset Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Rafferty Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 67k 15.68
2024-12-31 $192k 28k 6.94

More positions owned by Rafferty Asset Management

Ishares Tr 20 Yr Tr Bd Etf (TLT)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Broadcom (AVGO)
Advanced Micro Devices (AMD)
Micron Technology (MU)
Apple (AAPL)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Vaneck Etf Trust Gold Miners Etf (GDX)
Applied Materials (AMAT)
Ishares Tr China Lg-cap Etf (FXI)
Lam Research Corp Com New (LRCX)
Qualcomm (QCOM)
Kla Corp Com New (KLAC)

View all positions for Rafferty Asset Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics